Greater Paris Metropolitan Region
PhD-trained professional with 15+ years of experience in immunology, virology, immuno-oncology, and vaccine development. Extensive expertise in oncolytic virotherapy, viral vector vaccines, and in vivo models, with a strong focus on translating preclinical discoveries into clinical applications. At Oncovita (Institut Pasteur), led the development of in vivo tumor models to evaluate the efficacy and immune mechanisms of oncolytic measles virus, supporting its clinical translation. Experience includes potency assay development, biomarker discovery, documentation for preclinical trials and tech transfer to CDMOs. Keen on leveraging expertise in preclinical-to-clinical transition and immuno-oncology to contribute to the development of innovative therapies in the biotech and pharmaceutical industry. Open to opportunities in translational research, clinical development, or biomarker strategy.